Skip to main content

Jefferies Reaffirms Their Hold Rating on Novartis AG (NOVN)

Tipranks - Tipranks - Wed Feb 18, 1:38AM CST

Jefferies analyst James Vane maintained a Hold rating on Novartis AG today and set a price target of CHF110.00.

President's Day Sale - 70% Off

Vane covers the Healthcare sector, focusing on stocks such as SCHOTT Pharma AG & Co. KGaA, Gerresheimer, and Fresenius SE & Co. KGaA. According to TipRanks, Vane has an average return of -1.0% and a 49.13% success rate on recommended stocks.

In addition to Jefferies, Novartis AG also received a Hold from DZ BANK AG’s Elmar Kraus in a report issued on February 9. However, on February 12, Deutsche Bank maintained a Buy rating on Novartis AG (Six Swiss: NOVN).

See Insiders’ Hot Stocks on TipRanks >>

Based on Novartis AG’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF13.44 billion and a net profit of CHF2.43 billion. In comparison, last year the company earned a revenue of CHF13.56 billion and had a net profit of CHF2.82 billion

Read More on CH:NOVN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).